Curcumin in the Treatment of Various Diseases: Mechanism of Action, Bioavailability, Therapeutic Effects, and Current Clinical Trials
MedComm · 2026-11 · 7 (11)
DOI: 10.1002/mco2.71124 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 05.11.2026. Verfasst von Lin Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Neuropsychiatric Diseases Yunnan University of Chinese Medicine Kunmin…. Die Arbeit nennt 575 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Curcumin is a naturally occurring polyphenolic compound with anti‐inflammatory, antioxidant, antiapoptotic, and anticancer properties. Numerous studies have demonstrated that curcumin can regulate multiple molecular targets, including signaling pathways such as Toll‐like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MyD88)/nuclear factor kappa B (NF‐κB), Janus kinase (JAK)/signal transducer and activator of transcription (STAT), PTEN‐induced kinase 1 (PINK1)/Parkin, Parkin, phosphoinositide 3‐kinase (PI3K)/protein kinase B (Akt), mitogen‐activated protein kinase (MAPK), and nuclear factor erythroid 2‐related factor 2 (Nrf2)/antioxidant response element (ARE). Notably, curcumin exhibits therapeutic potential in a variety of diseases, including neurological disorders, cardiovascular diseases, cancer, inflammatory diseases, and autoimmune diseases. Its mechanisms of action are associated with the suppression of inflammation, regulation of mitochondrial dysfunction, inhibition of apoptosis, attenuation of oxidative stress, and enhancement of neuroplasticity. However, the extremely low oral bioavailability of curcumin limits its application in disease therapy. This review systematically summarizes recent advances in curcumin research, including its pharmacological properties, molecular mechanisms of action, and nanodelivery systems, such as nanoparticles, liposomes, nanoemulsions, polymeric micelles, and exosomes, which have been developed to enhance curcumin bioavailability. Furthermore, this review provides an in‐depth overview of the therapeutic benefits of curcumin in neurological disorders, cardiovascular diseases, cancer, inflammatory diseases, and autoimmune diseases. It focuses on evidence from in vitro studies, in vivo experiments, and potential clinical applications, while also discusses the therapeutic potential, current challenges, and future perspectives of curcumin in disease management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Neuropsychiatric Diseases Yunnan University of Chinese Medicine Kunming Yunnan China.
- College of Pharmaceutical Science Dali University Dali Yunnan China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Pan, Q., Long, W., Li, X., Mao, J., Zhou, S., Wang, Z., Zou, X., She, Y., Shi, M., Zhou, Y., Du, J., Hu, Z., Lv, X., Chen, Y., & Qin, D. (2026). Curcumin in the Treatment of Various Diseases: Mechanism of Action, Bioavailability, Therapeutic Effects, and Current Clinical Trials. MedComm, 7(11). https://doi.org/10.1002/mco2.71124
Vancouver
Wang L, Pan Q, Long W, Li X, Mao J, Zhou S, et al. Curcumin in the Treatment of Various Diseases: Mechanism of Action, Bioavailability, Therapeutic Effects, and Current Clinical Trials. MedComm. 2026;7(11). doi:10.1002/mco2.71124
BibTeX
@article{Wang2026,
author = {Wang, Lin and Pan, Qifei and Long, Wenjuan and Li, Xinyao and Mao, Jianqin and Zhou, Sitong and Wang, Zihui and Zou, Xuelian and She, Yuqing and Shi, Mingqin and Zhou, Yang and Du, Jiarong and Hu, Zhongyang and Lv, Xiaoman and Chen, Yishu and Qin, Dongdong},
title = {Curcumin in the Treatment of Various Diseases: Mechanism of Action, Bioavailability, Therapeutic Effects, and Current Clinical Trials},
journal = {MedComm},
year = {2026},
volume = {7},
number = {11},
doi = {10.1002/mco2.71124}
}
EUVIMED